About Us>Medical Advisory Board > Debu Tripathy, MD

Debu Tripathy, MD

Professor of Medicine & Chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center


His clinical research focuses on evaluating and developing novel therapeutics in breast cancer, specifically those targeting sensitivity and resistance mechanisms to growth factors, endocrine modulators, and cell cycle control pathways. He also investigates biomarkers predicting sensitivity and resistance. Dr. Tripathy has led clinical trials supporting the approval of new biological therapies for breast cancer targeting the HER2 oncogene and cyclin-dependent kinases, both improving patient survival.

Dr. Tripathy has published numerous original translational and landmark clinical research articles in the field of breast cancer. He serves on several editorial boards, study sections, and societies, and he is the editor-in-chief of CURE Magazine. He has previously served as president of the American Society of Breast Disease and of the Society of Integrative Oncology.